Gitterman Wealth Management LLC Has $283,000 Stock Holdings in DaVita Inc. (NYSE:DVA)

Gitterman Wealth Management LLC raised its position in DaVita Inc. (NYSE:DVA) by 20.6% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,698 shares of the company’s stock after buying an additional 460 shares during the quarter. Gitterman Wealth Management LLC’s holdings in DaVita were worth $283,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in DVA. Hanseatic Management Services Inc. acquired a new stake in shares of DaVita during the 3rd quarter worth $36,000. GAMMA Investing LLC acquired a new stake in shares of DaVita during the 4th quarter worth $60,000. FinTrust Capital Advisors LLC grew its holdings in shares of DaVita by 242.3% during the 3rd quarter. FinTrust Capital Advisors LLC now owns 712 shares of the company’s stock worth $67,000 after purchasing an additional 504 shares in the last quarter. Tacita Capital Inc acquired a new stake in shares of DaVita during the 3rd quarter worth $118,000. Finally, Federated Hermes Inc. grew its holdings in shares of DaVita by 1,284.4% during the 3rd quarter. Federated Hermes Inc. now owns 1,246 shares of the company’s stock worth $118,000 after purchasing an additional 1,156 shares in the last quarter. 90.12% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at DaVita

In other news, CEO Javier Rodriguez sold 67,603 shares of the firm’s stock in a transaction dated Monday, February 26th. The stock was sold at an average price of $126.11, for a total transaction of $8,525,414.33. Following the completion of the transaction, the chief executive officer now directly owns 488,697 shares in the company, valued at $61,629,578.67. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, CEO Javier Rodriguez sold 67,603 shares of the firm’s stock in a transaction dated Monday, February 26th. The stock was sold at an average price of $126.11, for a total transaction of $8,525,414.33. Following the completion of the transaction, the chief executive officer now directly owns 488,697 shares in the company, valued at $61,629,578.67. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider James O. Hearty sold 26,164 shares of the firm’s stock in a transaction dated Friday, February 16th. The stock was sold at an average price of $119.64, for a total value of $3,130,260.96. Following the transaction, the insider now owns 20,264 shares of the company’s stock, valued at $2,424,384.96. The disclosure for this sale can be found here. Over the last three months, insiders sold 134,540 shares of company stock worth $16,551,071. 1.40% of the stock is currently owned by insiders.

DaVita Trading Up 0.6 %

DaVita stock traded up $0.74 during trading hours on Friday, hitting $133.51. The stock had a trading volume of 477,673 shares, compared to its average volume of 478,110. The company has a quick ratio of 1.13, a current ratio of 1.19 and a debt-to-equity ratio of 6.65. The stock has a market cap of $11.71 billion, a price-to-earnings ratio of 18.04, a P/E/G ratio of 1.19 and a beta of 1.04. DaVita Inc. has a one year low of $71.51 and a one year high of $141.54. The business’s 50 day simple moving average is $132.12 and its 200-day simple moving average is $110.60.

DaVita (NYSE:DVA) last posted its earnings results on Tuesday, February 13th. The company reported $1.87 EPS for the quarter, beating the consensus estimate of $1.53 by $0.34. The firm had revenue of $3.15 billion during the quarter, compared to the consensus estimate of $3.01 billion. DaVita had a return on equity of 64.42% and a net margin of 5.70%. The business’s quarterly revenue was up 7.8% on a year-over-year basis. During the same period last year, the company earned $1.11 earnings per share. On average, equities analysts predict that DaVita Inc. will post 9.23 EPS for the current fiscal year.

Analysts Set New Price Targets

DVA has been the topic of several analyst reports. Truist Financial increased their target price on DaVita from $130.00 to $135.00 and gave the stock a “hold” rating in a report on Tuesday, February 20th. UBS Group raised their price objective on DaVita from $113.00 to $134.00 and gave the company a “buy” rating in a research note on Wednesday, February 14th. StockNews.com raised DaVita from a “buy” rating to a “strong-buy” rating in a research note on Thursday. Barclays began coverage on DaVita in a research note on Wednesday, March 6th. They issued an “equal weight” rating and a $133.00 price objective on the stock. Finally, TheStreet raised DaVita from a “c+” rating to a “b-” rating in a research note on Wednesday, February 7th. Two research analysts have rated the stock with a hold rating, one has assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $118.50.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.